Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Amneal Pharmaceuticals stock

Learn how to easily invest in Amneal Pharmaceuticals stock.

Amneal Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Amneal Pharmaceuticals shares (AMRX) are listed on the NYSE and all prices are listed in US Dollars. Amneal Pharmaceuticals employs 6,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Amneal Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AMRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Amneal Pharmaceuticals stock price (NYSE: AMRX)

Use our graph to track the performance of AMRX stocks over time.

Amneal Pharmaceuticals shares at a glance

Information last updated 2022-01-18.
Latest market close$4.40
52-week range$3.89 - $7.45
50-day moving average $4.64
200-day moving average $5.20
Wall St. target price$7.17
PE ratio 50.4348
Dividend yield N/A (0%)
Earnings per share (TTM) $0.09

Buy Amneal Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Amneal Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amneal Pharmaceuticals price performance over time

Historical closes compared with the close of $4.4 from 2022-01-20

1 week (2022-01-14) -5.17%
1 month (2021-12-18) N/A
3 months (2021-10-22) -22.40%
6 months (2021-07-22) -8.52%
1 year (2021-01-22) -11.47%
2 years (2020-01-21) -17.29%
3 years (2019-01-18) 12.42
5 years (2017-01-20) 12.05

Is Amneal Pharmaceuticals stock undervalued or overvalued?

Valuing Amneal Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amneal Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amneal Pharmaceuticals's P/E ratio

Amneal Pharmaceuticals's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 50x. In other words, Amneal Pharmaceuticals shares trade at around 50x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Amneal Pharmaceuticals's EBITDA

Amneal Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $435.8 million.

The EBITDA is a measure of a Amneal Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

Amneal Pharmaceuticals financials

Revenue TTM $2.1 billion
Operating margin TTM 9.85%
Gross profit TTM $652.3 million
Return on assets TTM 3.18%
Return on equity TTM 8.88%
Profit margin 0.68%
Book value $2.35
Market capitalisation $693.1 million

TTM: trailing 12 months

Amneal Pharmaceuticals share dividends

We're not expecting Amneal Pharmaceuticals to pay a dividend over the next 12 months.

Amneal Pharmaceuticals share price volatility

Over the last 12 months, Amneal Pharmaceuticals's shares have ranged in value from as little as $3.89 up to $7.445. A popular way to gauge a stock's volatility is its "beta".

AMRX.US volatility(beta: 1.32)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amneal Pharmaceuticals's is 1.3196. This would suggest that Amneal Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Amneal Pharmaceuticals overview

Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed, owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinson's disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.

Frequently asked questions

What percentage of Amneal Pharmaceuticals is owned by insiders or institutions?
Currently 10.745% of Amneal Pharmaceuticals shares are held by insiders and 69.153% by institutions.
How many people work for Amneal Pharmaceuticals?
Latest data suggests 6,000 work at Amneal Pharmaceuticals.
When does the fiscal year end for Amneal Pharmaceuticals?
Amneal Pharmaceuticals's fiscal year ends in December.
Where is Amneal Pharmaceuticals based?
Amneal Pharmaceuticals's address is: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
What is Amneal Pharmaceuticals's ISIN number?
Amneal Pharmaceuticals's international securities identification number is: US03168L1052
What is Amneal Pharmaceuticals's CUSIP number?
Amneal Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 03168L105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site